Cargando...
Drug Development for Severe Asthma: What Are the Metrics?
Although reversible airway obstruction in part defines asthma, lung function as measured by spirometry alone inadequately predicts the value of new therapeutic agents in the treatment of severe asthma. Our objectives are 1) to review whether pulmonary function and bronchodilator reversibility are en...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3383351/ https://ncbi.nlm.nih.gov/pubmed/22627271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2012.05.005 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|